OraQuick(R) Advance(TM) to Be Featured as Part of D.C Health Department's City-Wide HIV Testing Campaign Launch on June 27, 2006

--(BUSINESS WIRE)--OraSure Technologies, Inc. (NASDAQ: OSUR):

WHAT: OraSure Technologies, Inc. (NASDAQ: OSUR) will take part in the official launch of the D.C. Health Department's city-wide HIV testing campaign on June 27, National HIV Testing Day (NHTD).

The citywide campaign will encourage all District residents to learn their HIV status. The D.C. Health Department plans on distributing tests through a variety of settings including hospital emergency rooms, private physicians' offices, community health programs and public health settings.

OraSure's OraQuick(R) ADVANCE(TM) Rapid HIV-1/2 Antibody Test is the first and only U.S. FDA approved oral fluid rapid HIV test that can detect antibodies to both HIV-1 and HIV-2 in 20 minutes The test can be used not only with oral fluid, but also with finger-stick or venipuncture whole blood or plasma specimens - offering ease of use and accessibility in a variety of settings.

In observance of NHTD, OraSure's CEO and President Doug Michels will address the importance of HIV testing and prevention at a press conference hosted by the National Association of People With AIDS (NAPWA) on Monday, June 26. The Company will also join with NAPWA and POZ Magazine to Open the NASDAQ Stock Market on NHTD, as part of OraSure and NAPWA's Mayor's Campaign Against HIV(TM).

WHEN/WHERE

• National Association of People With AIDS Press Conference: June 26th, 9-11 AM, National Press Club's First Amendment Room, Washington DC
• District of Columbia HIV Testing Campaign Launch Event - June 27th, 10 AM, Freedom Plaza, Washington DC
• NASDAQ Opening Bell Ceremony - June 27th, 9 AM, at NASDAQ's MarketSite, New York City

INTERVIEWS AVAILABLE

MULTIMEDIA AVAILABLE:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5176854

CONTACT: Zer0 to 5ive for OraSure Technologies, Inc.
Erika Freed, 917-359-7974
erika@0to5.com

SOURCE: OraSure Technologies, Inc.